Lecture
BIH Lecture | Peter Gruss: “The Future of Healthcare: Harnessing New Technologies for Enhanced Longevity”.
In seinem Vortrag spricht Peter Gruss zu Instrumenten und Methoden, die personalisierte Medizin und regenerative Therapien nicht nur möglich, sondern zunehmend praktikabel für eine breite Anwendung machen.
Language
The online talk is part of the Lecture Series "Frontiers in Translational Medicine - Scientific and Structural Challenges" on key questions of translation in medicine.
This page is only available in English.
BIH Lecture
“The Future of Healthcare: Harnessing New Technologies for Enhanced Longevity”
The biomedical sciences stand at the threshold of a transformative decade. The convergence of precise molecular tools like CRISPR with comprehensive data analysis through omics technologies and artificial intelligence is revolutionizing our approach to healthcare. This powerful combination bridges the traditional gap between reductionist and holistic methodologies.
While reductionist approaches have given us unprecedented control over genetic modification and cellular processes, holistic analyses through big data and AI are revealing complex patterns in biological systems that were previously invisible. Together, these complementary approaches are opening new frontiers in addressing the healthcare challenges of our aging population.
This technological synergy enables precision personalized medicine, tailoring treatments to individual genetic profiles and disease characteristics. Additionally, advances in regenerative medicine offer promising solutions for age-related conditions and tissue repair. These developments are particularly crucial as we face the growing challenges of extended human longevity and its associated diseases.
In this talk, Gruss will explore the key technological innovations driving this revolution and examine how their integration is reshaping our ability to diagnose, treat, and potentially prevent major health challenges. He will look at specific tools and methodologies that are making personalized medicine and regenerative therapies not just possible, but increasingly practical for widespread implementation.
About the Speaker
Peter Gruss is a German cell and microbiologist and long-serving president of the Max Planck Society. Among restructuring many institutes he established eight new Max Planck Institutes with innovative topics, such as Biology of Aging, Physics of Light, or Empirical Aesthetics. Two institutes located abroad were also added during his tenure.
He has made significant contributions to understanding genetic and molecular processes in embryonic development, providing insights into the formation of tissues and organs. In experiments with mice, the developmental biologist identified important controlling genes, called paired-box genes (Pax genes), which regulate the development of various organs. The Pax4 gene discovered by Gruss is a tissue-specific transcription factor required for the development of insulin-producing beta cells in the pancreas. Without this gene, mammalian embryos lack functional beta cells, meaning the pancreas cannot produce insulin. Building on these findings, Peter Gruss's team succeeded in differentiating stem cells into insulin-producing cells. They also identified the Pax6 gene, which is involved in the development of the iris and is essential for eye function. Thus, Peter Gruss has significantly influenced both stem cell research and regenerative medicine.
Info
When:
February 28, 2025
12:00 - 1:00 pm
How:
Online via Zoom
The login data will be provided shortly before the event.
Registration:
Please register here.
